Choose Your Country or Region

Vemurafenib (PLX4032)

Name: Vemurafenib (PLX4032)
Brand: Selleck Chemicals
SKU: S1267
Rating: 5 (532 reviews)

Catalog No.S1267 Synonyms: RG7204, RO5185426

For research use only.

Vemurafenib (PLX4032, RG7204, RO5185426) is a novel and potent inhibitor of B-Raf^V600E with IC50 of 31 nM in cell-free assay. 10-fold selective for B-Raf^V600E over wild-type B-Raf in enzymatic assays and the cellular selectivity can exceed 100-fold. Vemurafenib (PLX4032, RG7204) induces autophagy.

Vemurafenib (PLX4032) Chemical Structure

CAS No. 918504-65-1

Selleck's Vemurafenib (PLX4032) has been cited by 532 publications

Purity & Quality Control

Choose Selective Raf Inhibitors

Related Compound Libraries

Other Raf Products

Download Inhibitor Catalog

Raf Signaling Pathway Map

Biological Activity

Description

Features

A novel and potent inhibitor of the B-RAF^V600E oncoprotein.

Targets

SRMS ^[1] (Cell-free assay)	ACK1 ^[1] (Cell-free assay)	B-Raf (V600E) ^[1] (Cell-free assay)	C-Raf ^[1] (Cell-free assay)	MAP4K5 (KHS1) ^[1] (Cell-free assay)	Click to View More Targets
18 nM	19 nM	31 nM	48 nM	51 nM	Click to View More Targets

In vitro

PLX4032 inhibits B-RAF^V600E, C-RAF, as well as wildtype B-RAF, with IC50 of 31 nM, 48 nM and 100 nM, respectively. PLX4032 also inhibits several non-RAF kinases, including ACK1, KHS1, and SRMS, with IC50 of 18 nM to 51 nM. ^[1] In melanoma cell lines, the inhibitory effect by PLX4032 depends on B-RAF mutational status, because PLX4032 potently inhibits those harboring B-RAF V600 mutants, including V600E, V600D, V600K, and V600R, but not wildtype or other mutants. The IC50 values of PLX4032 on these cells, including MALME-3M, Colo829, Colo38, A375, SK-MEL28, and A2058, ranges from 20 nM to 1 μM. In these cells, PLX4032 (0.1 μM to 30 μM) also inhibits the phosphorylation of both MEK1/2 and ERK1/2. ^[2] PLX4032 is highly effective in the treatment of melanoma, for its ability of inhibiting B-RAF^V600E. However, PLX4032 displays limited effect in colon cancer patients that also carrying B-RAF^V600E oncoprotein. The reason for this is that, in colon cancer cells, B-RAF^V600E inhibition by PLX4032 results in a rapid feedback EGFR activation, which compensates for the PLX4032-inhibited cell proliferation. ^[3]

Cell Data

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID

SKMEL19	M{HR[WZ2dmO2aX;uJGF{e2G7	NUfaVFl7PiEQvF2=	NVTGeINvPDhiaB?=	M175fWROW09?	NXmxcVJMXHKrZ3fldpMhTVJic4Ty[ZN{	M1qwNlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ\|M{[yNlQxLz5{M{O2NlI1ODxxYU6=
VMM12	M3nBW2Z2dmO2aX;uJGF{e2G7	NIfGfGY{KM7:TR?=	M2nCWFQ5KGh?	Mk\uSG1UVw>?	M1;YUmlv[3KnYYPld{Bkd2yuYXflckB{gW62aHXzbZMh[W6mIHTlZ5Jm[XOnczDJUE06KGW6cILld5Nqd25?	MoXRQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV7OEm1NFYoRjJ3OUi5OVA3RC:jPh?=
C4	NHXTd4JHfW6ldHnvckBCe3OjeR?=	NW\JVXA3OyEQvF2=	MY[0PEBp	MUXEUXNQ	MoTWTY5kemWjc3XzJINwdGyjZ3XuJJN6dnSqZYPpd{BidmRiZHXjdoVie2W\|IFnMMVgh\XiycnXzd4lwdg>?	NInybZg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUm4PVUxPid-MkW5PFk2ODZ:L3G+
Calu-6	MWXGeY5kfGmxbjDBd5NigQ>?	M4DEc\|HjiIoQvF2=	MlLnNUBp	M3fFXGROW09?	M1n5dGFkfGm4YYTld{BOTUtxRWLLJIlvKGOnbHzzJJdqfGhid3ns[E11gXCnIFLSRWY>	NEfZUI09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEG3PVcxPSd-MkCxO\|k4ODV:L3G+
PC	MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NHfqdY86PiCq		MX7FR\|UxRiBzMECwJI5O	MYC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTh6MEe5Nkc,OTl6OEC3PVI9N2F-
TPC-1 (RET/PTC1)	MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NYHUPJRbQTZiaB?=		NXLaSnBVTUN3MPMJqVExODBibl2=	MmnOQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl6OEC3PVIoRjF7OEiwO\|kzRC:jPh?=
CAL62 (KRAS G12R) > 1000 > 1000	NF7YTWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MoLiPVYhcA>?		MUjFR\|UxRiBzMECwJI5O	MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTh6MEe5Nkc,OTl6OEC3PVI9N2F-
HTH7 (NRAS Q61R)	M1LOSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MoPhPVYhcA>?		NWL3cXJNTUN3MPMJqUAyODByIH7N	Mn3GQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl6OEC3PVIoRjF7OEiwO\|kzRC:jPh?=
C643 (HRAS G13R)≥ 500	NIHzOo9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NX7sdZdxQTZiaB?=		MVLFR\|UxKOLLpTC1NFAhdk1?	NGr2[FI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUi4NFc6Oid-MUm4PFA4QTJ:L3G+
BCPAP (BRAF WT/V600E)	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M3K0d\|k3KGh?		M13BRWVEPTB;N{igcm0>	M33FRVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7OEiwO\|kzLz5zOUi4NFc6OjxxYU6=
BHT101 (BRAF WT/V600E)	M3jxfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MUS5OkBp		M1rXfmVEPTB;OUegcm0>	NGfW[2w9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUi4NFc6Oid-MUm4PFA4QTJ:L3G+
SW1736 (BRAF WT/V600E)	NUnJUXhNT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NW\BWZg5QTZiaB?=		M3LkUWVEPTB;Mkmgcm0>	NHzXWGY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUi4NFc6Oid-MUm4PFA4QTJ:L3G+
8505C (BRAF V600E/V600E)	MoXJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MnrPPVYhcA>?		MmDlSWM2OD13NzDuUS=>	NF\xZYE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUi4NFc6Oid-MUm4PFA4QTJ:L3G+
ARO	MVHGeY5kfGmxbjDBd5NigQ>?	MVyxNEDPxE1?	MoDjO\|IhcA>?	NULpVZBHTE2VTx?=	NWPKR5FGUW6mdXPld{B1cGVicnXlfJBz\XO\|aX;uJI9nKHSqZTDOTXMheHWvcB?=	NIrrVI89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOES1PFA2Oyd-MUi0OVgxPTN:L3G+
A375	MXPBdI9xfG:\|aYOgRZN{[Xl?	MXKxNEDPxE1?		M3vOc2ROW09?	NHXiT\|JRem:vb4Tld{BieG:ydH;0bYMh\GWjdHi=	M3n4WFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NEW4NFU{Lz5zOES1PFA2OzxxYU6=
TPCI	MmfES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NFnP[mcyODBizszN	NWDXXFNRQTZiaB?=	NYXJW2pYTE2VTx?=	MknwTWM2OD1zMD63O{DPxE1?	NGDPTJg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOES1PFA2Oyd-MUi0OVgxPTN:L3G+
ARO	NX7ISGRiT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NV[3PGpvOTByIN88US=>	MlHkPVYhcA>?	NH\3OYxFVVOR	M3\VOmlEPTB;MkC1JI5O	NXrYT5V7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi0OVgxPTNpPkG4OFU5ODV\|PD;hQi=>
NPA	MnHzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NIfxfHAyODBizszN	NG\aPWM6PiCq	MVPEUXNQ	NVvvZpRpUUN3ME2yOkBvVQ>?	NED3Wpk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOES1PFA2Oyd-MUi0OVgxPTN:L3G+
A375	Mm\jS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MmHpNVAxKM7:TR?=	NV;jR29[QTZiaB?=	NVKyR3dXTE2VTx?=	NFnSNpRKSzVyPUS3JI5O	M{mxb\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NEW4NFU{Lz5zOES1PFA2OzxxYU6=
UKF-NB-3 (ABCB1)	MVfGeY5kfGmxbjDBd5NigQ>?	NIGxcYgyNjJ3INM1US=>	MVWyJIg>	MoO0SG1UVw>?	NV7HNZpjTW6qYX7j[ZMh[WOldX31cIF1cW:wIH;mJJRp\SCobIXvdoV{[2WwdDDBRmNDOSC\|dXLzeJJifGVicnjv[IFucW6nIEGyNy=>	MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDd\|NUe2Okc,OjR5M{W3OlY9N2F-
UKF-NB-3	MYfGeY5kfGmxbjDBd5NigQ>?	NWHVTIxoOS5{NTFCuW0>	MnHTNkBp	NU\jdlFJTE2VTx?=	MVPTbYdvcW[rY3HueIx6KGGoZnXjeJMhd25iYXPjeY12dGG2aX;uJI9nKHSqZTDmcJVwemW\|Y3XueEBCSkOEMTDzeYJ{fHKjdHWgdohw\GGvaX7lJFEzOw>?	M3HsbFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2N{O1O\|Y3Lz5{NEezOVc3PjxxYU6=
A375 (BRAFV600E)	NGXtPGRHfW6ldHnvckBCe3OjeR?=		MXq4JIg>	NWLaS4xPTE2VTx?=	NH3QelRKdmO{ZXHz[ZMhcW62cnHj[YxtfWyjcjDSU3Mh[W6mIF7PJIxmfmWucx?=	NUnacXo6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWzOlM3PDRpPkK1N\|Y{PjR2PD;hQi=>
A375P	MXjBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>?				MXHBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEF\|N{XQJINmdGy\|LDDJR\|UxKD1iMD6yOVQh\|ryPLh?=	M4DNZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{NE[wNFMxLz5{MkS2NFA{ODxxYU6=
A375	MkX5RY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl?				NWrEZZpVSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDBN\|c2KGOnbHzzJIV5eHKnc4PpcochSi2UYX[gWlYxOEVibYX0ZY51KGGwZDD3bYxlKHS7cHWgVoF{NCCLQ{WwJF0hOC5\|MTFOwG0v	NVj5[o5yRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK4NFg6OTFpPkKyPFA5QTFzPD;hQi=>
A375P	NUHhXoh6SW62aYDyc4xq\mW{YYTpeoUh[XO\|YYm=		M{W4PVQ5KGi{cx?=		M3;xVmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQUO3OXAh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IECuNlUh\|ryPLh?=	NGfSW3k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEGyPFQyOCd-MkSxNlg1OTB:L3G+
A375	Mo[zR5l1d3SxeHnjbZR6KGG\|c3H5		M4rX[FczKGi{cx?=		NH7pUFZEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBCOzd3IHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUAxNjF6IN88UU4>	M3niOVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2MkG1PFE5Lz5{NEKxOVgyQDxxYU6=
SK-MEL-28	NV\nS4k{S3m2b4TvfIlkcXS7IHHzd4F6				MWPDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDTT{1OTUxvMkigZ4VtdHNiZYjwdoV{e2mwZzDCMZJi\iCYNkCwSUBufXSjboSsJGlEPTBiPTCwMlEh\|ryPLh?=	Mn;SQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR2N{G0OlYoRjJ2NEexOFY3RC:jPh?=
M229	M4jEN2N6fG:2b4jpZ4l1gSCjc4PhfS=>				M1Hq[mN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJG0zOjliY3XscJMh\XiycnXzd4lv\yCELYLh[kBXPjByRTDteZRidnRuIFnDOVAhRSByLkGg{txONg>?	M2nPdFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2NEexOFY3Lz5{NES3NVQ3PjxxYU6=
M263	NVf0e3o5S3m2b4TvfIlkcXS7IHHzd4F6				MWrDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDNNlY{KGOnbHzzJIV5eHKnc4PpcochSi2{YX[gWlYxOEVibYX0ZY51NCCLQ{WwJF0hOC5zIN88UU4>	NInxfIQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NES3NVQ3Pid-MkS0O\|E1PjZ:L3G+
M321	NGLXeHFEgXSxdH;4bYNqfHliYYPzZZk>				NWqwV5JDS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hVTN{MTDj[YxteyCneIDy[ZN{cW6pIFKtdoFnKFZ4MEDFJI12fGGwdDygTWM2OCB;IECuNUDPxE1w	MlzLQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR2N{G0OlYoRjJ2NEexOFY3RC:jPh?=
M238	NGTBfIxEgXSxdH;4bYNqfHliYYPzZZk>				MXfDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDNNlM5KGOnbHzzJIV5eHKnc4PpcochSi2{YX[gWlYxOEVibYX0ZY51NCCLQ{WwJF0hOC5zIN88UU4>	MkHzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR2N{G0OlYoRjJ2NEexOFY3RC:jPh?=
M262	NE\1bmFEgXSxdH;4bYNqfHliYYPzZZk>				NH;jTmdEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBOOjZ{IHPlcIx{KGW6cILld5NqdmdiQj3yZYYhXjZyMFWgcZV1[W62LDDJR\|UxKD1iMD6xJO69VS5?	Mn;VQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR2N{G0OlYoRjJ2NEexOFY3RC:jPh?=
M249	M{fVNWN6fG:2b4jpZ4l1gSCjc4PhfS=>				MXjDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDNNlQ6KGOnbHzzJIV5eHKnc4PpcochSi2{YX[gWlYxOEVibYX0ZY51NCCLQ{WwJF0hOC5zIN88UU4>	NXm4So4zRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS0O\|E1PjZpPkK0OFcyPDZ4PD;hQi=>
M14	M3\TUmN6fG:2b4jpZ4l1gSCjc4PhfS=>				Mlu5R5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUVE1KGOnbHzzJIV5eHKnc4PpcochVlKDUzDHNVJEKG23dHHueEwhUUN3MDC9JFAvOTVizszNMi=>	MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDR5MUS2Okc,OjR2N{G0OlY9N2F-
SK-MEL-28	NWf0XHBsSW62aYDyc4xq\mW{YYTpeoUh[XO\|YYm=		MYe2PEBpenN?		NWD2WnhYSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDTT{1OTUxvMkigZ4VtdHNiaHHyZo9zcW6pIFLSRWYhXjZyMFWgcZV1[W62IHHmeIVzKDZ6IHjyd{BjgSCPVGOgZZN{[XluIFnDOVAhRSByLkS4JO69VS5?	MlOwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR3OEiwO\|MoRjJ2NUi4NFc{RC:jPh?=
insect cell	MVLGeY5kfGmxbjDhd5NigQ>?		M2jYR\|YxKG2rboO=		NHzrco1KdmirYnn0bY9vKG:oIH\1cIwhdGWwZ4ToJIh2dWGwIFKtVoFnKFZ4MEDFJI12fGGwdDDlfJBz\XO\|ZXSgbY4h[mGldXzveolzfXNiaX7m[YN1\WRiaX7z[YN1KGOnbHzzJIF{e2W\|c3XkJIF{KFupYX3tZU0{O1CfaX7jc5Jxd3KjdHnvckBqdnSxIF3FT{Bi\nSncjC2NEBucW6\|IHL5JJNkcW62aXzsZZRqd25iY3;1cpRqdmduIFnDOVAhRSByLkCzNUDPxE1w	NVHnUG1URGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS5NFA{OTVpPkK0PVAxOzF3PD;hQi=>
MALME-3M	NVr1XGF7TnWwY4Tpc44h[XO\|YYm=		M4\ldVEhcHJ?		MXvJcohq[mm2aX;uJI9nKEJvUnHmJHY3ODCHIH31eIFvfC2vZXTpZZRm\CCHcnugdIhwe3Cqb4L5cIF1cW:wIHnuJIh2dWGwIF3BUG1GNTOPIHPlcIx{KGGodHXyJFEhcHJiYomg[ox2d3Knc3PlcoNmKGGwYXz5d4l{NCCLQ{WwJF0hOC5yNkGg{txONg>?	MV68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDlyMEOxOUc,OjR7MECzNVU9N2F-
A375	NYfQfnltTnWwY4Tpc44h[XO\|YYm=		NH2yZ4wyKGi{		MUfJcohq[mm2aX;uJI9nKEJvUnHmJHY3ODCHIH31eIFvfC2vZXTpZZRm\CCHcnugdIhwe3Cqb4L5cIF1cW:wIHnuJIh2dWGwIFGzO\|Uh[2WubIOgZYZ1\XJiMTDodkBjgSCobIXvdoV{[2WwY3WgZY5idHm\|aYOsJGlEPTBiPTCwMlE6KM7:TT6=	MoraQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR7MECzNVUoRjJ2OUCwN\|E2RC:jPh?=
COLO205	M1XjWGN6fG:2b4jpZ4l1gSCjc4PhfS=>		MVW0JIRigXN?		MmfzR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gR29NVzJyNTDj[YxteyCjZoTldkA1KGSjeYOgZpkhS2WubGTpeIVzNUeubzDhd5NigSxiRVO1NEA:KDBwMkSg{txONg>?	MlLJQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR7MECzNVUoRjJ2OUCwN\|E2RC:jPh?=
WM266.4	MUnBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>?		MlPWOFghcHK\|		M2OxdGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iV12yOlYvPCClZXzsd{Bi\nSncjC0PEBpenNiYomgUXRVKGG\|c3H5MEBKSzVyIE2gNE4xPiEQvF2u	MlPWQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV{NkewNFYoRjJ3Mk[3NFA3RC:jPh?=
A375	M2HBb2FvfGmycn;sbYZmemG2aY\lJIF{e2G7		NEHPS3o1QCCqcoO=		MXXBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEF\|N{WgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KE2WVDDhd5NigSxiSVO1NEA:KDBwMUmg{txONg>?	NI\NPFc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUK2O\|AxPid-MkWyOlcxODZ:L3G+
WM1361	NUnCZmRESW62aYDyc4xq\mW{YYTpeoUh[XO\|YYm=		MVi0PEBpenN?		MWXBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKFePMUO2NUBk\WyuczDh[pRmeiB2ODDodpMh[nliTWTUJIF{e2G7LDDJR\|UxKD1iMT64O{DPxE1w	MlGzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV{NkewNFYoRjJ3Mk[3NFA3RC:jPh?=
A375	NVXteo5YTnWwY4Tpc44h[XO\|YYm=				Ml\oTY5pcWKrdHnvckBw\iCELYLh[kBXPjByRTDteZRidnRiaX6gbJVu[W5iQUO3OUBk\WyuczDhd5Nme3OnZDDhd{Bz\WS3Y4Tpc44hcW5iRWLLNU8zKHCqb4PwbI9zgWyjdHnvckBqdmO3YnH0[YQh\m:{IEmwJI1qdnNiYomgW4V{fGW{bjDicI91fGmwZzDt[ZRpd2RuIFnDOVAhRSByLkCzN\|Eh\|ryPLh?=	Mn71QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV2NkKyOlcoRjJ3NE[yNlY4RC:jPh?=
A375	MXXBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>?		MnOxO\|IhcHK\|		M1LISmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQUO3OUBk\WyuczDh[pRmeiB5MjDodpMh[nliQ1PLPEBie3OjeTygTWM2OCB;IEOuN\|E2KM7:TT6=	M2PUOlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NE[yNlY4Lz5{NUS2NlI3PzxxYU6=
SK-MEL-2	MoTVSpVv[3Srb36gZZN{[Xl?				M1jl[2lvcGmkaYTpc44hd2Zid3ns[EB1gXCnIFKtdoFnKGmwIHj1cYFvKFONLV3FUE0zKGOnbHzzJIF{e2W\|c3XkJIF{KHKnZIXjeIlwdiCrbjDFVmsyNzJicHjvd5Bpd3K7bHH0bY9vKGmwY4XiZZRm\CCob4KgPVAhdWmwczDifUBY\XO2ZYLuJIJtd3S2aX7nJI1mfGixZB?=	MmLlQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV2NkKyOlcoRjJ3NE[yNlY4RC:jPh?=
A375	NWTwbVZETnWwY4Tpc44h[XO\|YYm=		M2jpS\|czKGi{cx?=		M4[3emlvcGmkaYTpc44hd2ZiQmLBSkBXPjByRTDteZRidnRiaX6gbJVu[W5iQUO3OUBk\WyuczDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIFXST{BxcG:\|cHjvdplt[XSrb36gcYVie3W{ZXSgZYZ1\XJiN{KgbJJ{KGK7IFXMTXNCKGG\|c3H5MEBKSzVyIE2gNE4yPSEQvF2u	M3TidlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OU[1PFA1Lz5{NUm2OVgxPDxxYU6=
A375	MYjBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>?		MXG3NkBpenN?		MXHBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEF\|N{WgZ4VtdHNiYX\0[ZIhPzJiaILzJIJ6KHKnc3H6eZJqdiCjc4PhfUwhUUN3MDC9JFAvOTdizszNMi=>	NWXwV4hKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW5OlU5ODRpPkK1PVY2QDB2PD;hQi=>
A375	MY\GeY5kfGmxbjDhd5NigQ>?		NHnSRVIyPSCvaX7z		NXKwTWRJS2:vcHX0bZRqfmViYnnu[Ilv\yCjZn\pcol1gSC2bzDCVmFHKGmwIHj1cYFvKEF\|N{WgZ4VtdHNiYX\0[ZIhOTVibXnud{BqdiCycnXz[Y5k\SCxZjDBWHAh[W6jbH;neYUtKEmFNUCgQUAxNjJ4IN88UU4>	MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTl4NUiwOEc,OjV7NkW4NFQ9N2F-
A375	NHrTeINHfW6ldHnvckBie3OjeR?=		NWTvboZxOTVibXnudy=>		NVf0UoRES2:vcHX0bZRqfmViYnnu[Ilv\yCjZn\pcol1gSC2bzDBVmFHKGmwIHj1cYFvKEF\|N{WgZ4VtdHNiYX\0[ZIhOTVibXnud{BqdiCycnXz[Y5k\SCxZjDBWHAh[W6jbH;neYUtKEmFNUCgQUAxNjl3IN88UU4>	M1\0[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OU[1PFA1Lz5{NUm2OVgxPDxxYU6=
HCT116	NYLufHd1TnWwY4Tpc44h[XO\|YYm=				NVLFPXJkUW6qaXLpeIlwdiCxZjDLVmFUKEdzM1SgcZV1[W62IHnuJIh2dWGwIFjDWFEyPiClZXzsd{Bie3Onc4Pl[EBieyCrbnjpZol1cW:wIH;mJGVTUyCyaH;zdIhwenmuYYTpc44h[nliRVzJV2EtKEmFNUCgQUAyPi54IN88UU4>	NITmN3E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUm2OVgxPCd-MkW5OlU5ODR:L3G+
HCT116	NEXJd2pHfW6ldHnvckBie3OjeR?=	MX[wMlM1KHSxIEKwNFAxKG6P			MWDQZZJi\G:6aXPhcEBi[3SrdnH0bY9vKG:oIGLBV{9TSUZxTVXLJJNq\26jbHnu[{Bx[XSqd3H5JIlvKGi3bXHuJGhEXDFzNjDj[YxteyCneIDy[ZN{cW6pIIfpcIQhfHmyZTDCVmFHKGG\|c3Xzd4VlKGG\|IFXST{BxcG:\|cHjvdplt[XSrb36gZZQhOC5\|NDD0c{AzODByMDDuUS=>	NVjjfpFPRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW5OlU5ODRpPkK1PVY2QDB2PD;hQi=>
NZM20	M1jXfmFvfGmycn;sbYZmemG2aY\lJIF{e2G7		M2rnNVY5KGi{cx?=		NUiwZYE2SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDOXm0zOCClZXzsd{BmgHC{ZYPzbY5oKEJvUnHmJHY3ODCHIH31eIFvfCCrc3;sZZRm\CCocn;tJG5mfyCcZXHsZY5lKG2ndHHzeIF1cWNibXXsZY5wdWFicHH0bYVvfCCrbnP1ZoF1\WRiZn;yJFY5KGi{czDifUBUWkJiYYPzZZktKEmFNUCgQUAxNjB{NDFOwG0v	M3zpdVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4MEC1OVMxLz5{NkCwOVU{ODxxYU6=
NZM07	MXjBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>?		MnrmOlghcHK\|		MlHtRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDoeY1idiCQWl2wO{Bk\WyuczDlfJBz\XO\|aX7nJGIuWmGoIG[2NFBGKG23dHHueEBqe2:uYYTl[EBnem:vIF7le{Bb\WGuYX7kJI1mfGG\|dHH0bYMhdWWuYX7vcYEheGG2aXXueEBqdmO3YnH0[YQh\m:{IE[4JIhzeyCkeTDTVmIh[XO\|YYmsJGlEPTBiPTCwMlA{PiEQvF2u	MlzNQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZyMEW1N\|AoRjJ4MEC1OVMxRC:jPh?=
A375	NW\ucJB6SW62aYDyc4xq\mW{YYTpeoUh[XO\|YYm=		MVu2PEBpenN?		MoXiRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDoeY1idiCDM{e1JINmdGy\|IHX4dJJme3OrbnegRk1T[WZiVk[wNGUhdXW2YX70JIlv[3WkYYTl[EBnd3JiNkigbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IECuNFc6KM7:TT6=	NF:zOJU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NkCwOVU{OCd-Mk[wNFU2OzB:L3G+
COLO205	NWHYSoMySW62aYDyc4xq\mW{YYTpeoUh[XO\|YYm=		NYnwcplNPjhiaILz		M4DhWGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQ1;MU\|IxPSClZXzsd{BmgHC{ZYPzbY5oKEJvUnHmJHY3ODCHIH31eIFvfCCrbnP1ZoF1\WRiZn;yJFY5KGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUAxNjNyOTFOwG0v	NIrlfZI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NkCwOVU{OCd-Mk[wNFU2OzB:L3G+
SK-MEL-28	NV3Q[GJESW62aYDyc4xq\mW{YYTpeoUh[XO\|YYm=		NYHiNpJ3PjhiaILz		MnntRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDoeY1idiCVSz3NSWwuOjhiY3XscJMh\XiycnXzd4lv\yCELWLh[kBXPjByRTDteZRidnRiaX7jeYJifGWmIH\vdkA3QCCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOC5\|OEGg{txONg>?	NEOxV3c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NkCwOVU{OCd-Mk[wNFU2OzB:L3G+
HT-29	NVq4WpBmSW62aYDyc4xq\mW{YYTpeoUh[XO\|YYm=		MnPnOlghcHK\|		NIrZXI5CdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjUMVI6KGOnbHzzJIV5eHKnc4PpcochSi2UYX[gWlYxOEVibYX0ZY51KGmwY4XiZZRm\CCob4KgOlghcHK\|IHL5JG1VXCCjc4PhfUwhUUN3MDC9JFAvPjBzIN88UU4>	M2LPPFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4MEC1OVMxLz5{NkCwOVU{ODxxYU6=
SK-MEL-1	MX3BcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>?		NFrKdZM3QCCqcoO=		MnPhRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDoeY1idiCVSz3NSWwuOSClZXzsd{BmgHC{ZYPzbY5oKEJvUnHmJHY3ODCHIH31eIFvfCCrbnP1ZoF1\WRiZn;yJFY5KGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUAyNjR7OTFOwG0v	MnjXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZyMEW1N\|AoRjJ4MEC1OVMxRC:jPh?=
NZM40	NUPEc5FGSW62aYDyc4xq\mW{YYTpeoUh[XO\|YYm=		NYq2dWtCPjhiaILz		NET5VVZCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF7aUVQxKGOnbHzzJIV5eHKnc4Ppcochf2muZDD0fZBmKEJvUnHmJIl{d2yjdHXkJIZzd21iTnX3JHpm[WyjbnSgcYV1[XO2YYTpZ{Bu\Wyjbn;tZUBx[XSrZX70JIlv[3WkYYTl[EBnd3JiNkigbJJ{KGK7IGPSRkBie3OjeTygTWM2OCB;IEOuNFEh\|ryPLh?=	NHvoUok9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NkCwOVU{OCd-Mk[wNFU2OzB:L3G+
NZM09	MYTBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>?		NX3mfXN{PjhiaILz		MoTHRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDoeY1idiCQWl2wPUBk\WyuczDlfJBz\XO\|aX7nJJdqdGRidInw[UBDNVKjZjDpd49t[XSnZDDmdo9uKE6ndzDa[YFt[W6mIH3leIF{fGG2aXOgcYVt[W6xbXGgdIF1cWWwdDDpcoN2[mG2ZXSg[o9zKDZ6IHjyd{BjgSCVUlKgZZN{[XluIFnDOVAhRSB6LkOzJO69VS5?	M3vOZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4MEC1OVMxLz5{NkCwOVU{ODxxYU6=
A375P	M3jaSGFvfGmycn;sbYZmemG2aY\lJIF{e2G7		MUS3NkBpenN?		Ml\vRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDoeY1idiCDM{e1VEBk\WyuczDlfJBz\XO\|aX7nJGJTSUZiVk[wNGUhdXW2YX70JIFnfGW{IEeyJIhzeyCkeTDD[YxtXGm2ZYKtS4xwKGG\|c3H5MEBKSzVyIE2gNE4{PyEQvF2u	MYe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjd{NEezNEc,OjZ5MkS3N\|A9N2F-
BL21(DE3)	MkK4SpVv[3Srb36gZZN{[Xl?				NUnoNnE6UW6qaXLpeIlwdiCxZjDOMZRmem2rbnHsJIhqey22YXfn[YQhSlKDRjDWOlAxTSCvdYThcpQhMDR2ODD0c{A4OjNicnXzbYR2\XNrIDj1cotvd3ewIH;ybYdqdiliZYjwdoV{e2WmIHnuJGV{[2incnnjbIliKGOxbHmgRmwzOSiGRUOpJINmdGy\|IHHzd4V{e2WmIHHzJJBpd3OyaH;yfYxifGmxbjDv[kBjcW:2aX75cIF1\WRvTVXLJIJ6KEGucHjhV4Nz\WWwIHHzd4F6NCCLQ{WwJF0hOC5yM{Gg{txONg>?	MnTLQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZ6NUK2NlMoRjJ4OEWyOlI{RC:jPh?=
A375	MnTJSpVv[3Srb36gZZN{[Xl?		NI\mOZQyKGi{		M3zNfWlvcGmkaYTpc44hd2ZiQj3SZYYhXjZyMFWgcZV1[W62IHnuJIh2dWGwIFGzO\|Uh[2WubIOgZZN{\XO\|ZXSgZZMhTVKNIIDoc5NxcG:{eXzheIlwdiCycnXpcoN2[mG2ZXSg[o9zKDFiaIKgZpkhX2W\|dHXyckBjdG:2IH3leIhw\CxiSVO1NEA:KDBwMEG3JO69VS5?	M2DjNFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5MEi1OlczLz5{N{C4OVY4OjxxYU6=
MIAPaCa2	MknZSpVv[3Srb36gZZN{[Xl?		NWnicWtDOSCqch?=		M13BdWlvcGmkaYTpc44hd2Zid3ns[EB1gXCnIFKtVoFnKGmwIHj1cYFvKE2LQWDhR4EzKGOnbHzzJIF{e2W\|c3XkJIF{KHKnZIXjeIlwdiCrbjDFVmsheGixc4Doc5J6dGG2aX;uJJBz\WmwY4XiZZRm\CCob4KgNUBpeiCkeTDX[ZN1\XKwIHLsc5QhdWW2aH;kMEBGSzVyIE2gNk4zQSEQvF2u	M3rTZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5MEi1OlczLz5{N{C4OVY4OjxxYU6=
COLO205	NULxPWpmS3m2b4TvfIlkcXS7IHHzd4F6		NVzYfZY3PzJiaILz		M1PwXGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGNQVE9{MEWgZ4VtdHNiaHHyZo9zcW6pIFKtVoFnKFZ4MEDFJI12fGGwdDDhd5Nme3OnZDDhd{Boem:5dHigbY5pcWKrdHnvckBi\nSncjC3NkBpenNiYomgUXRVKGG\|c3H5MEBKSzVyIE2gNE4xPDRizszNMi=>	MnzSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjdzNUW4PVkoRjJ5MUW1PFk6RC:jPh?=
HT-29	MWDDfZRwfG:6aXPpeJkh[XO\|YYm=		NXHlZXc1PzJiaILz		M1G3emN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGhVNTJ7IHPlcIx{KGijcnLvdolv\yCELWLh[kBXPjByRTDteZRidnRiYYPz[ZN{\WRiYYOg[5Jwf3SqIHnubIljcXSrb36gZYZ1\XJiN{KgbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IECuNVU3KM7:TT6=	NFKxV5o9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{G1OVg6QSd-MkexOVU5QTl:L3G+
HCT116	M1r2T2N6fG:2b4jpZ4l1gSCjc4PhfS=>		NEDoeXc4OiCqcoO=		NF;hVmREgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBJS1RzMU[gZ4VtdHNiaHHyZo9zcW6pIIfpcIQhfHmyZTDCMXJi\iCjc4Pld5Nm\CCjczDndo94fGhiaX7obYJqfGmxbjDh[pRmeiB5MjDodpMh[nliTWTUJIF{e2G7LDDJR\|UxKD1iMUSuOVgh\|ryPLh?=	M174UVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5MUW1PFk6Lz5{N{G1OVg6QTxxYU6=
WM266.4	MU\BcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>?		M4fQ[VI1KGi{cx?=		Ml\URY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDoeY1idiCZTUK2Ok41KGOnbHzzJIF{e2W\|c3XkJIF{KGOnbHygeoli[mmuaYT5JIFnfGW{IEK0JIhzeyCkeTDNWHQh[XO\|YYmsJGdKPTBiPTCwMlIyKM7:TT6=	MonKQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjd{M{i4OFEoRjJ5MkO4PFQyRC:jPh?=
WM266.4	M13ST2FvfGmycn;sbYZmemG2aY\lJIF{e2G7		MnX6NlQhcHK\|		MU\BcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKFePMk[2MlQh[2WubIOgbIFz[m:{aX7nJGJTSUZiVk[wNGUhdXW2YX70JIF{e2W\|c3XkJIF{KGOnbHyg[5Jwf3SqIHnubIljcXSrb36gZYZ1\XJiMkSgbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IECuNFch\|ryPLh?=	MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzZ\|NEG5OUc,Ojd4M{SxPVU9N2F-
A375	NE\KPWxCdnSrcILvcIln\XKjdHn2[UBie3OjeR?=		NV3ZXWFbOjRiaILz		NUXpT4d6SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDBN\|c2KGOnbHzzJIF{e2W\|c3XkJIF{KGOnbHyg[5Jwf3SqIHnubIljcXSrb36gZYZ1\XJiMkSgbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IECuNlEh\|ryPLh?=	M4XDe\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5NkO0NVk2Lz5{N{[zOFE6PTxxYU6=
WM1361	NGX1TlVCdnSrcILvcIln\XKjdHn2[UBie3OjeR?=		MnHZNlQhcHK\|		MV;BcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKFePMUO2NUBk\WyuczDhd5Nme3OnZDDhd{Bk\WyuIHfyc5d1cCCrbnjpZol1cW:wIHHmeIVzKDJ2IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSBzLki2JO69VS5?	MmPhQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjd4M{SxPVUoRjJ5NkO0NVk2RC:jPh?=
SK-MEL-28	NUjiUZRjSW62aYDyc4xq\mW{YYTpeoUh[XO\|YYm=		NIHU[nQ1QCCqcoO=		M1jtdGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iU1utUWVNNTJ6IHPlcIx{KGijcnLvdolv\yCEUlHGJHY3ODCHIH31eIFvfCCjc4Pld5Nm\CCjczDjc45k\W62cnH0bY9vKHKncYXpdoVlKG[xcjD0c5RidCCpcn;3eIghcW6qaXLpeIlwdiCvZXHzeZJm\CCjZoTldkA1QCCqcoOgdoV{[Xq3cnnuJIF{e2G7LDDUS2khRSB{IN88UU4>	NFf4NJk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{e3OFE{Pyd-Mke3O\|QyOzd:L3G+
SK-MEL-28	MnT0S5Jwf3SqIHnubIljcXSrb36gZZN{[Xl?		MUmxJIhz		NIeyfJZIem:5dHigbY5pcWKrdHnvckBw\iCqdX3hckBUUy2PRVytNlgh[2WubIOgbIFz[m:{aX7nJGJTSUZiVk[wNGUhdXW2YX70JJBz\WmwY4XiZZRm\CCob4KgNUBpeiCob3zsc5dm\CCkeTDpdpJi\GmjdHnvckBw\iBzLkGzJItYN21{IGXWMYxq\2i2IH\vdkA2KG2rboOgcYVie3W{ZXSgZYZ1\XJiNEigbJJ{KHKnc3H6eZJqdiCjc4PhfS=>	M{Ph[VxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5N{e0NVM4Lz5{N{e3OFE{PzxxYU6=
A375	MVfBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>?		M{L1flczKGi{cx?=		MmrxRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgbJVu[W5iQUO3OUBk\WyuczDh[pRmeiB5MjDodpMh[nliY3XscEB1cXSncj3ncI8hdHWvaX7ld4NmdmOnIHHzd4F6NCCLQ{WwJF0hOC55IN88UU4>	MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDJ2MkW1N{c,Ojh{NEK1OVM9N2F-
COLO205	M2fIS2FvfGmycn;sbYZmemG2aY\lJIF{e2G7		MVu3NkBpenN?		MXLBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDoeY1idiCFT1zPNlA2KGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDj[YxtKHSrdHXyMYdtdyCudX3pcoV{[2WwY3WgZZN{[XluIFnDOVAhRSB3LkG2JO69VS5?	MXq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDJ2MkW1N{c,Ojh{NEK1OVM9N2F-
HepG2	M1X6NWFvfGmycn;sbYZmemG2aY\lJIF{e2G7		NFLlbVY4OiCqcoO=		M17PfGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIh2dWGwIFjldGczKGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDj[YxtKHSrdHXyMYdtdyCudX3pcoV{[2WwY3WgZZN{[XluIFnDOVAhRSB3LkS4JO69VS5?	NGXKT\|I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEK0NlU2Oyd-MkiyOFI2PTN:L3G+
SK-MEL-2	NIjG[nJCdnSrcILvcIln\XKjdHn2[UBie3OjeR?=		NUfrVYg6PzJiaILz		NET3UWtCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBpfW2jbjDTT{1OTUxvMjDj[YxteyCjZoTldkA4OiCqcoOgZpkh[2WubDD0bZRmei2pbH:gcJVucW6nc3PlcoNmKGG\|c3H5MEBKSzVyIE2gOU43PCEQvF2u	MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDJ2MkW1N{c,Ojh{NEK1OVM9N2F-
K562	NVywRYd1TnWwY4Tpc44h[XO\|YYm=		M4H0c\|EhcHJ?		MoX3V5Ri[mmuaYrheIlwdiCxZjDCVmFHKGmwIHj1cYFvKEt3NkKgZ4VtdHNiYX\0[ZIhOSCqcjDifUB1cGW{bXHsJJNpcW[2IHHzd4F6NCCHQ{WwJF0hOC55OUSzN{DPxE1w	MmrzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh{OECyOlEoRjJ6MkiwNlYyRC:jPh?=
K562	NXrIXogzTnWwY4Tpc44h[XO\|YYm=		NYXEenFSOSCqch?=		M3nEOXN1[WKrbHn6ZZRqd25ib3[gSmVEUCCrbjDoeY1idiCNNU[yJINmdGy\|IHHmeIVzKDFiaIKgZpkhfGincn3hcEB{cGmodDDhd5NigSxiRVO1NEA:KDVwMEGxPFch\|ryPLh?=	NG\FZ4g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEK4NFI3OSd-MkiyPFAzPjF:L3G+
A375M	M2ricmFvfGmycn;sbYZmemG2aY\lJIF{e2G7		M13rNlczKGi{cx?=		MXvBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEF\|N{XNJINmdGy\|IHjhdoJwemmwZzDCVmFHKFZ4MEDFJI12fGGwdDDh[pRmeiB5MjDodpMh[nliTWTUJIF{e2G7LDDJR\|UxKD1iMD61JO69VS5?	MkTZQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh2NUixN\|QoRjJ6NEW4NVM1RC:jPh?=
1205 Lu	NWW3OHVFSW62aYDyc4xq\mW{YYTpeoUh[XO\|YYm=		NFnqVFU4OiCqcoO=		MULBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKDF{MEWgUJUh[2WubIOgbIFz[m:{aX7nJGJTSUZiVk[wNGUhdXW2YX70JIFnfGW{IEeyJIhzeyCkeTDNWHQh[XO\|YYmsJGlEPTBiPTCyJO69VS5?	M1W2blxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6NEW4NVM1Lz5{OES1PFE{PDxxYU6=
A375M	NX\GdIFHSW62aYDyc4xq\mW{YYTpeoUh[XO\|YYm=		MmG3OFghcHK\|		M{jGdGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQUO3OW0h[2WubIOgbIFz[m:{aX7nJGJTSUZiVk[wNGUhdXW2YX70JIFnfGW{IES4JIhzeyCkeTDNWHQh[XO\|YYmsJGlEPTBiPTCyMlA2KM7:TT6=	NVXKeY9wRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMki0OVgyOzRpPkK4OFU5OTN2PD;hQi=>
UACC-903	MljvRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl?		NUm5dnZQPzJiaILz		NIjSWWhCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGXBR2MuQTB\|IHPlcIx{KGijcnLvdolv\yCEUlHGJHY3ODCHIH31eIFvfCCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOi55IN88UU4>	NUflU4FHRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMki0OVgyOzRpPkK4OFU5OTN2PD;hQi=>
1205 Lu	NFr4c3BCdnSrcILvcIln\XKjdHn2[UBie3OjeR?=		NXS3R2dmPDhiaILz		MUDBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKDF{MEWgUJUh[2WubIOgbIFz[m:{aX7nJGJTSUZiVk[wNGUhdXW2YX70JIFnfGW{IES4JIhzeyCkeTDNWHQh[XO\|YYmsJGlEPTBiPTC3MlYh\|ryPLh?=	MonjQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh2NUixN\|QoRjJ6NEW4NVM1RC:jPh?=
UACC-903	MmO5RY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl?		NYi2XlBXPDhiaILz		MVfBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKFWDQ1OtPVA{KGOnbHzzJIhiemKxcnnu[{BDWkGIIG[2NFBGKG23dHHueEBi\nSncjC0PEBpenNiYomgUXRVKGG\|c3H5MEBKSzVyIE2gNVIvOyEQvF2u	MojiQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh2NUixN\|QoRjJ6NEW4NVM1RC:jPh?=
CHL-1	MmfnRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl?		NGPUT4k4OiCqcoO=		MUjBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEOKTD2xJINmdGy\|IHjhdoJwemmwZzD3bYxlKHS7cHWgRnJCTiCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOTJwNzFOwG0v	M{LuUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6NEW4NVM1Lz5{OES1PFE{PDxxYU6=
CHL-1	MorJRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl?		NVPoRW1FPDhiaILz		NV[1b5BXSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDDTGwuOSClZXzsd{Bp[XKkb4Lpcochf2muZDD0fZBmKEKUQV[gZYZ1\XJiNEigbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IEKwJO69VS5?	M{\STFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6NEW4NVM1Lz5{OES1PFE{PDxxYU6=
HCT116	NG\DdXlHfW6ldHnvckBie3OjeR?=				NI\lW5VUfGmvdXzheIlwdiCxZjDCVmFHNUOUQV[g[Ilu\XKrenH0bY9vKGmwIHj1cYFvKEiFVEGxOkBk\WyuczDifUBtfWOrZnXyZZNmKGOxbYDs[Y1mdnSjdHnvckBie3OjeTygSWM2OCB;IECuOlAyKM7:TT6=	MnH2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh3NUe0OVgoRjJ6NUW3OFU5RC:jPh?=
Calu6	NUnre2xmTnWwY4Tpc44h[XO\|YYm=	NYnyOHpTOyC3TR?=	MXSyJIhzew>?		NULjbmhtSWO2aY\heIlwdiCxZjDDVmFHKGmwIHj1cYFvKEOjbIW2JINmdGy\|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKE2HSzDwbI9{eGixconsZZRqd25iYYSgN{B2VSCjZoTldkAzKGi{czDifUBHWkWWIHHzd4F6	M17TZ\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6NUW3OFU5Lz5{OEW1O\|Q2QDxxYU6=
Sf9	MUHGeY5kfGmxbjDhd5NigQ>?		NWnicHNrOSCqch?=		MVjJcohq[mm2aX;uJI9nKGi3bXHuJHpCUyBqNTD0c{A{ODlicnXzbYR2\XNrIHX4dJJme3OnZDDpckBj[WO3bH;2bZJ2eyCrbn\lZ5Rm\CCVZkmgbY5{\WO2IHPlcIx{KHW\|aX7nJHpCU3SrZHWgZZMhe3Wkc4TyZZRmKGGodHXyJFEhcHJiYomgcYF{eyC\|cHXjeJJwdWW2comsJGlEPTBiPTCwMlAzOyEQvF2u	M3uzdlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6NUi2NlEyLz5{OEW4OlIyOTxxYU6=
Sf9	NVrVXWFSTnWwY4Tpc44h[XO\|YYm=		MVmzNEBucW6\|		NVP2R5lGUW6qaXLpeIlwdiCxZjDOMZRmem2rbnHsJGdUXC22YXfn[YQhemWlb33ibY5idnRiaIXtZY4h\nWubD3s[Y5ofGhiWlHLJIV5eHKnc4Pl[EBqdiCkYXP1cI93cXK3czDpcoZm[3SnZDDT[lkhcW6\|ZXP0JINmdGy\|IIXzbY5oKE2EUDDhd{B{fWK\|dILheIUh[W[2ZYKgN\|AhdWmwczDifUBCTFBvR3zvJIF{e2G7LDDJR\|UxKD1iMD6wN\|E1KM7:TT6=	NILFdpY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEW4OlIyOSd-Mki1PFYzOTF:L3G+
UACC-903	NFvWco1EgXSxdH;4bYNqfHliYYPzZZk>	MmOzNlUhfU1?	NHG0dlg1QCCqcoO=		MX7DfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDVRWNENTlyMzDj[YxteyCjc4Pld5Nm\CCjczDj[YxtKH[rYXLpcIl1gSCjdDCyOUB2VSCjZoTldkA1QCCqcoOgZpkhVVSWIHHzd4F6KHKnbHH0bZZmKHSxIHPvcpRzd2xuIFnDOVAhRSB\|Lk[g{txONg>?	MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTF\|M{CzOUc,OjlzM{OwN\|U9N2F-
CHL-1	M2HNOmFvfGmycn;sbYZmemG2aY\lJIF{e2G7		NVPXT\|cyPzJiaILz		NWXzTJBGSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDDTGwuOSClZXzsd{Bp[XKkb4Lpcochf2muZDD0fZBmKEKUQV[gZYZ1\XJiN{KgbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IEGzMlch\|ryPLh?=	NXnnW5QzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkmxN\|MxOzVpPkK5NVM{ODN3PD;hQi=>
A375	MV\GeY5kfGmxbjDhd5NigQ>?		MXe5OkBpenN?		MXXJcohq[mm2aX;uJI9nKEKUQV[gWlYxOEVibYX0ZY51KGmwIHj1cYFvKEF\|N{WgZ4VtdHNiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJIlvKGOnbHygdJJwdGmoZYLheIlwdiCrbnP1ZoF1\WRiZn;yJFk3KGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUAxNjF{NzFOwG0v	NYrmPWxxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0NFc6PzdpPkK5OFA4QTd5PD;hQi=>
A375	Mme0SpVv[3Srb36gZZN{[Xl?				M2TDfWlvcGmkaYTpc44hd2ZiQmLBSkBXPjByRTDteZRidnRiaX6gbJVu[W5iQUO3OUBk\WyuczDhd5Nme3OnZDDhd{Bz\WS3Y4Tpc44hcW5iRWLLJJBpd3OyaH;yfYxifGmxbjDifUBCdHCqYWPjdoVmdiCjc4PhfUwhUUN3MDC9JFAvODN{IN88UU4>	MXW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR4MUiyO{c,Ojl2NkG4Nlc9N2F-
SK-MEL-32	NEHkcZdEgXSxdH;4bYNqfHliYYPzZZk>				NFLoWWpEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBUUy2PRVytN\|Ih[2WubIOsJGlEPTBiPTCwMlMyKM7:TT6=	NXLVOHY{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0OlE5OjdpPkK5OFYyQDJ5PD;hQi=>
WM266.4	M1z4PWFvfGmycn;sbYZmemG2aY\lJIF{e2G7		MXu0PEBpenN?		NYDI[lJrSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDXUVI3Pi52IHPlcIx{KGGodHXyJFQ5KGi{czDifUBOXFRiYYPzZZktKEeLNUCgQUAxNjJzIN88UU4>	M3PFTVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7OUSwOFY{Lz5{OUm0NFQ3OzxxYU6=
A375	M{HIRmFvfGmycn;sbYZmemG2aY\lJIF{e2G7		NIDKXZU1QCCqcoO=		NIjiSWJCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFGzO\|Uh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IF3UWEBie3OjeTygS2k2OCB;IECuPVUh\|ryPLh?=	MmTQQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl7NEC0OlMoRjJ7OUSwOFY{RC:jPh?=
HT-29	NXi5dGVySW62aYDyc4xq\mW{YYTpeoUh[XO\|YYm=		NWW2W2F1PDhiaILz		MYTBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEiWLUK5JINmdGy\|IHHmeIVzKDR6IHjyd{BjgSCPVGSgZZN{[XluIFfJOVAhRSBzLki4JO69VS5?	NX;MNGpFRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm5OFA1PjNpPkK5PVQxPDZ\|PD;hQi=>
WM1361	MUDBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>?		MWq0PEBpenN?		M{GxcmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iV12xN\|YyKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDNWHQh[XO\|YYmsJGdKPTBiPTCyNE45KM7:TT6=	NGnie4Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUm0NFQ3Oyd-Mkm5OFA1PjN:L3G+
HCT116	MnfLRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl?		MVG0PEBpenN?		NUnpWnBnSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDIR3QyOTZiY3XscJMh[W[2ZYKgOFghcHK\|IHL5JG1VXCCjc4PhfUwhT0l3MDC9JFI2NjJizszNMi=>	M1HRSVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7OUSwOFY{Lz5{OUm0NFQ3OzxxYU6=
A673	MWrxTHRUKGG\|c3H5				NXfaNVdyeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC\|Y4Ll[Y4h\m:{IFG2O\|Mh[2WubIO=	NEPDV2E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N\|UyOzl:L3G+
DAOY	MlPTdWhVWyCjc4PhfS=>				NV;DUHlReUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC\|Y4Ll[Y4h\m:{IFTBU3kh[2WubIO=	MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR\|NUGzPUc,Ojl2M{WxN\|k9N2F-
RD	NHHR[2RyUFSVIHHzd4F6				MmnKdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[\|ohWHKrbXHyfUB{[3KnZX6g[o9zKFKGIHPlcIx{	M334[FxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
SK-N-SH	NELWOG5yUFSVIHHzd4F6				M3[0SZFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCVSz3OMXNJKGOnbHzz	MoK3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN\|koRjJ7NEO1NVM6RC:jPh?=
MG 63 (6-TG R)	NEDHc3VyUFSVIHHzd4F6				M{m3N5FJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCPRzC2N{ApPi2WRzDSLUBk\Wyucx?=	NIPqS3g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N\|UyOzl:L3G+
NB1643	M1rscpFJXFNiYYPzZZk>				MXzxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW\|IH\vdkBlenWpIILldJVzeG:\|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhVkJzNkSzJINmdGy\|	MlXKQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN\|koRjJ7NEO1NVM6RC:jPh?=
OHS-50	MmCxdWhVWyCjc4PhfS=>				MX7xTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW\|IH\vdkBlenWpIILldJVzeG:\|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhV0iVLUWwJINmdGy\|	M1rleFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
A673	NWLH[lFFeUiWUzDhd5NigQ>?				Ml\rdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[\|ohS2:wZnnycYF1d3K7IIPjdoVmdiCob4KgRVY4OyClZXzsd{k>	NV;zfII1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N\|UyOzlpPkK5OFM2OTN7PD;hQi=>
U-2 OS	Mm\ldWhVWyCjc4PhfS=>				NXTsSJpGeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiQ3;u[olzdWG2b4L5JJNkemWnbjDmc5IhXS1{IF;TJINmdGy\|	MoL6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN\|koRjJ7NEO1NVM6RC:jPh?=
Rh41	M3PiRZFJXFNiYYPzZZk>				M1G5bJFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KEOxbn\pdo1ifG:{eTDzZ5Jm\W5iZn;yJHJpPDFiY3XscJM>	M3j2WFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
SJ-GBM2	M4nZeJFJXFNiYYPzZZk>				MULxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW\|IH\vdkBlenWpIILldJVzeG:\|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhW0pvR1LNNkBk\Wyucx?=	NYLacJp5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N\|UyOzlpPkK5OFM2OTN7PD;hQi=>
SK-N-MC	NWfBWWlkeUiWUzDhd5NigQ>?				NVvTNHNzeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC\|Y4Ll[Y4h\m:{IGPLMW4uVUNiY3XscJM>	M{nXXFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
LAN-5	NGX4ZplyUFSVIHHzd4F6				MlP4dWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[\|ohWHKrbXHyfUB{[3KnZX6g[o9zKEyDTj21JINmdGy\|	NXLDNop[RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N\|UyOzlpPkK5OFM2OTN7PD;hQi=>
SK-N-MC	M331dpFJXFNiYYPzZZk>				NW\pOFFyeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiQ3;u[olzdWG2b4L5JJNkemWnbjDmc5IhW0tvTj3NR{Bk\Wyucx?=	MnTpQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN\|koRjJ7NEO1NVM6RC:jPh?=
TC32	MlzUdWhVWyCjc4PhfS=>				M13kVZFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KEOxbn\pdo1ifG:{eTDzZ5Jm\W5iZn;yJHREOzJiY3XscJM>	MlLqQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN\|koRjJ7NEO1NVM6RC:jPh?=

Click to View More Cell Line Experimental Data

Assay

Methods	Test Index	PMID

Western blot	p-ERK / p-CRAF ; p-MEK(S217/221) / pAKT(T308) / p-AKT(S473) / p-P70 S6K(T389) / p-S6(Ser235-236) / P-4EB-P1 ; Bax / Bcl2 / Bcl-xl / BIM / Mcl1	22448344 22194965 28382170
Growth inhibition assay	Cell viability	29179510
Immunofluorescence	uPAR / α5-β1 ; p-Akt(Thr308)	30611716 27293997

In vivo

In B-RAF^V600E-mutant mice xenograft models, PLX4032 (6 mg/kg–20 mg/kg) inhibits tumor growth. ^[1] In mice xenograft models of LOX, Colo829, and A375 cells, PLX4032 (12.5 mg/kg–100 mg/kg) inhibits tumor growth and prolongs mice survival. ^[2]

Protocol (from reference)

Kinase Assay: ^[1]	RAF kinase activity measurements: The kinase activities of wild-type RAF and mutants are determined by measuring phosphorylation of biotinylated-BAD protein. For each enzyme (0.01 ng), 20 μL reactions are carried out in 20 mM Hepes (pH 7.0), 10 mM MgCl₂, 1 mM DTT, 0.01% (v/v) Tween-20, 50 nM biotin-BAD protein, and 1 mM ATP at room temperature. Reactions are stopped at 5 min with 5 μL of a solution containing 20 mM Hepes (pH 7.0), 200 mM NaCl, 80 mM EDTA, 0.3% (w/v) bovine serum albumin (BSA). The stop solution also includes phospho-BAD (Ser112) antibody, streptavidin-coated donor beads, and protein A acceptor beads. The antibody and beads are pre-incubated in stop solution in the dark at room temperature for 30 min. The final dilution of antibody is 1/2000 and the final concentration of each bead is 10 μg/mL. The assay plates are incubated at room temperature for one hour and then are read on a PerkinElmer AlphaQuest reader. Mutant activities are the average of two different batches of purified protein assayed in duplicate in three different experiments.
Cell Research: ^[2]	Cell lines: MALME-3M, Colo829, Colo38, A375, SK-MEL28, and A2058 cells Concentrations: 0–10 μM , dissolved in DMSO Incubation Time: 5 days Method: Cellular proliferation is evaluated by MTT assay. Briefly, cells are plated in 96-well microtiter plates at a density of 1000 to 5000 cells per well in a volume of 180 μL. PLX4032 is prepared at 10 times the final assay concentration in media containing 1% DMSO. Twenty-four hours after cell plating, 20 μL of the appropriate dilution of PLX4032 are added to plates in duplicate. The plates are assayed for proliferation 6 days after the cells are plated. Percent inhibition is calculated and the IC50 is determined from the regression of a plot of the logarithm of the concentration versus percent inhibition. (Only for Reference)
Animal Research: ^[2]	Animal Models: Mice (athymic nude) xenograft models of LOX, Colo829, and A375 cells Dosages: 12.5 mg/kg–100 mg/kg Administration: Oral gavage twice daily (Only for Reference)

References

+ Expand

Solubility (25°C)

In vitro	DMSO	97 mg/mL (197.99 mM)
	Water	Insoluble
	Ethanol	Insoluble
In vivo	Add solvents to the product individually and in order (Data is from Selleck tests instead of citations): 4% DMSO+30% PEG 300+5% Tween 80+61% ddH2O For best results, use promptly after mixing. Click to purchase: PEG300 Tween 80	1.25mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight	489.92
Formula	C₂₃H₁₈ClF₂N₃O₃S
CAS No.	918504-65-1
Storage	3 years	-20°C	powder
Storage	2 years	-80°C	in solvent
Smiles	CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F

Download Vemurafenib (PLX4032) SDF

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

Dosage: mg/kg Average weight of animals: g Dosing volume per animal:μL Number of animals:

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO + % + % Tween 80 + % ddH₂O

%DMSO+ %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH₂O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Dilution Calculator Molecular Weight Calculator

Clinical Trial Information

NCT Number	Recruitment	Interventions	Conditions	Sponsor/Collaborators	Start Date	Phases
NCT05068752	Recruiting	Drug: Vemurafenib\|Drug: Sorafenib	Pancreas Cancer	HonorHealth Research Institute\|Bayer\|Genentech Inc.	October 28 2021	Phase 2
NCT03410875	Active not recruiting	Drug: Vemurafenib\|Drug: Obinutuzumab	Hairy Cell Leukemia\|Leukemia\|Leukemia Hairy Cell	Memorial Sloan Kettering Cancer Center\|Dana-Farber Cancer Institute\|Yale University	February 9 2018	Phase 2
NCT03013491	Active not recruiting	Drug: CX-072\|Drug: ipilimumab\|Drug: vemurafenib	Solid Tumor\|Lymphoma	CytomX Therapeutics	January 2017	Phase 1\|Phase 2
NCT02441465	Completed	Drug: Vemurafenib\|Drug: 14C-Labeled Vemurafenib	Malignant Melanoma Cancer	Hoffmann-La Roche	August 13 2015	Phase 1

(data from https://clinicaltrials.gov, updated on 2022-01-17)

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Frequently Asked Questions

Question 1:
How about the half-life of Vemurafenib(S1267)?

Answer:
It was reported that the half-life of the compound is 57 hours.

Question 2:
The vemurafenib power, when prepared in 4% DMSO/30% PEG 300/5% Tween 80/ddH2O solutions, form a pellet down the tube?

Answer:
When prepare this kind of vehicle, please dissolve the drug in DMSO clearly first. If it dissolves not readily, please sonicate and warm in the water bath at about 45 degree. Then add PEG and Tween. After they mixed homogeneously, then dilute with water.

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):